Wednesday, 20th November
4th Metabolic Diseases; Breakthrough Discoveries in Diabetes & Obesity Meeting 2024
Days
Sunday, 17th November
Monday, 18th November
Tuesday, 19th November
Wednesday, 20th November
Search
Speakers
Session 6: Neural control of metabolism
8:30AM - 10:30AM
Wednesday, 20th November
Heritage Ballroom
Chairs: Kim Loh & Garron Dodd
GPCRs controlling food intake and body composition
-
Lora Heisler
Sympathetic regulation of metabolic activities
-
Wenwen Zeng
Critical role of brainstem NPFF neuronal circuits in the control of torpor-like states
-
Herbert Herzog
Pathogenic hypothalamic extracellular matrix promotes metabolic disease
-
Cait A Beddows
Intestinal melanocortin-4 receptor mediated peptide YY secretion decreases food intake and body weight in mice
-
Rifa T Haque
Morning Tea, Networking & Poster Viewing
10:30AM - 11:00AM
Wednesday, 20th November
Convention Rooms 1 - 3
Session 7: Metabolic dysfunction & complications
11:00AM - 1:00PM
Wednesday, 20th November
Heritage Ballroom
Chairs: Jacqueline Stoeckli & Josephine Forbes
Harnessing the power of hepatokines for therapeutic gain
-
Matthew Watt
From fasting to wasting: the hepatocentric view
-
Stephan Herzig
A new role of the Y4 receptor signalling in regulating beta cell function and islet transplantation outcomes
-
Yanchuan Shi
Early mitochondrial dysfunction aligns with risk for kidney disease in diabetes
-
Mitchell A Sullivan
Single Cell Transcriptomic Analysis in a Model of Metabolic Associated Steatohepatitis (MASH) Reveals Sex Specific Differences in the Liver Repair Response
-
Brian G Drew
Mechanisms of Endothelial Dysfunction in a Novel Model of Sustained Hyperphagia and Obesity in Mice using a Brain Targeting Adeno-Associated Virus
-
David JR Fulton
Lunch, Networking & Poster Viewing
1:00PM - 2:00PM
Wednesday, 20th November
Convention Rooms 1 - 3
Session 8: Therapeutics
2:00PM - 4:00PM
Wednesday, 20th November
Heritage Ballroom
Chairs: Denise Wootten & Kyle Hoehn
Innovation in Obesity Therapy: Current Status and Future Opportunities
-
James Trevaskis
Obtaining Quality Weight loss in the Treatment of Obesity
-
Mark Sleeman
The pre-clinical exploration of small molecule approaches in obesity
-
Robert Dullea
Relative contributions of GIPR activity in dual incretin agonist effects on whole-body metabolism
-
Dana Hutchinson
Effect of a protein kinase C epsilon inhibitor in glucose tolerance and the liver proteome and phosphoproteome in fat-fed mice
-
Carsten Schmitz-Peiffer
Targeting Protein Tyrosine Phosphatases for Combating Obesity and Type 2 Diabetes
-
Chrysovalantou E Xirouchaki
Awards & Closing Remarks
4:15PM - 4:30PM
Wednesday, 20th November
Heritage Ballroom
Chairs: Tony Tiganis & Zane Andrews
← Tuesday